Patheon final_logo-01The complexity of drug product supply chains has increased in recent years, thanks mainly to the development of more complex chemical molecules (with more synthesis steps), more suppliers and geographies in the chain, and reduced average production volumes.

Lukas Utiger, President Drug Substance, and Mike Mencer, Vice President PDS Operations & Global Integrated Offering, from Patheon, offer a white paper that explores four steps to create a harmonized and integrated supply chain.